Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ERN-EuroBloodNet European Collaborative Platform to Share COVID-19 Data in Patients With Red Blood Cell Disorders in Real Time

NCT06831799 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT06831799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06831799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ERN-EuroBloodNet European Collaborative Platform to Share COVID-19 Data in Patients With Red Blood Cell Disorders in Real Time
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Observational
Overall status
Completed
Start date
April 15, 2020
Completion date
December 31, 2023
Enrollment
684 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alpha-thalassemia, beta thalassemia intermedia, beta thalassemia major, beta-thalassemia, delta-beta thalassaemia, dominant beta-thalassemia, elliptocytosis, hereditary, enzyme disorder; anemia, haemoglobin c-beta-thalassaemia syndrome, hemoglobin barts hydrops, hemoglobin e-beta thalassemia, hemoglobin h disease, hemoglobinopathies, hereditary persistence of fetal hemoglobin thalassemia, membranes; disorder, sickle beta thalassemia, sickle cell anemia, sickle cell disease, sickle cell hemoglobin c, sickle cell hemoglobin d, sickle cell-hemoglobin e disease, sickle-cell; hemoglobinopathy, spherocytosis, hereditary, stomatocytosis